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Hypophysiotropic TRH-synthesizing neurons of the hypothalamic paraventricular nucleus (PVN)
have a critical role in the regulation of the energy homeostasis through control of the hypotha-
lamic-pituitary-thyroid axis. Recently, endocannabinoids have been shown to exert inhibitory ef-
fectsonTRHneuronsvia the type1cannabinoid receptor (CB1). Tounderstand theanatomicalbasis
for this regulatory mechanism, we determined whether CB1 is contained in axons innervating
hypophysiotropic TRH neurons using a recently developed antiserum against the C-terminal por-
tion ofmouse CB1. CB1-immunoreactive axons densely innervated the parvicellular subdivisions of
the PVN where the hypophysiotropic TRH neurons are located. By double-labeling immunocyto-
chemistry, CB1-immunoreactive varicosities were observed in juxtaposition to the vast majority of
TRH neurons in the PVN. At the ultrastructural level, CB1-immunoreactivity was observed in the
preterminal portion of axons establishing both symmetric and asymmetric synaptic specializations
with the perikarya and dendrites of TRH neurons in the PVN. These data demonstrate that CB1 is
abundantly present in axons that are in synaptic association with hypophysiotropic TRH neurons,
indicating an important role for endocannabinoids in the regulation of the hypothalamic-pitu-
itary-thyroid axis. The presence of both symmetric and asymmetric type CB1 synapses on TRH
neurons in the PVN suggests that endocannabinoids may influence both excitatory and inhibitory
inputs of these neurons. (Endocrinology 150: 98–103, 2009)
Hypophysiotropic TRH-synthesizing neurons residing in theparvicellular subdivisions of the hypothalamic paraven-
tricular nucleus (PVN) are the main central regulators of the
hypothalamic-pituitary-thyroid (HPT) axis and, therefore, have
a critical role in the regulation of peripheral thyroid hormone
levels (1). Because thyroid hormones increase basal metabolic
rate (2), fasting-induced inhibitionof thehypophysiotropicTRH
neurons and the resultant fall in peripheral thyroid hormone
levels may be an important homeostatic response mediated by
the fall in peripheral leptin levels to improve survival during the
period of food restriction (1, 3).
The endocannabinoid signaling system uses arachidonic
acid derivatives anandamide and 2-arachidonoyl-glycerol as
signaling molecules (4). These bioactive lipid mediators are
widely synthesized in the central nervous system where they
act primarily by binding to type 1 cannabinoid receptors
(CB1) (4). Endocannabinoids are synthesized and released
from postsynaptic neurons, whereas CB1 is present in pre-
synaptic terminals (4). This retrograde signaling system en-
ables neurons to regulate their own synaptic input by modi-
fying transmitter release fromCB1-containing axon terminals
(4, 5).
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A large body of evidence suggests a critical role for CB1 in the
modulation of food intake and energy balance (6); central ad-
ministration of endocannabinoids increases food intake (7), and
CB1 knockout mice eat less after food restriction and have de-
creased body weight (8). In addition, the hypothalamic level of
endocannabinoids increases during fasting and is reduced by
leptin administration (7, 9).
Because the parvicellular neurons of the PVN are densely
innervated by CB1-containing axon terminals (10), the CB1 ag-
onist, 9-tetrahydrocannabinol (9THC), inhibits the HPT axis
(11), and endocannabinoids have a CB1 receptor-mediated, di-
rect effect on the TRH neurons in the PVN (12), we determined
whether CB1-containing axon terminals are in an anatomical
position to directly regulate hypophysiotropic TRH neurons.
Materials and Methods
Animals
Adult male CD1 mice (n  7) weighing 25–30 g were used in the
experiments. The animals were housed under standard environmental
conditions (light between 0600 and 1800 h, temperature 22  1 C,
rodent chow and water ad libitum). All experimental protocols were
reviewedandapprovedby theAnimalWelfareCommittee at the Institute
of Experimental Medicine of the Hungarian Academy of Sciences.
Tissue preparation for light microscopic
immunocytochemistry
Three mice were deeply anesthetized with sodium pentobarbital (35
mg/kg bodyweight, ip) and treated intracerebroventricularly with 30g
colchicine under stereotaxic control. One day later, the animals were
overdosed with pentobarbital (50 mg/kg body weight, ip) and perfused
transcardially with 10 ml 0.01 M PBS (pH 7.4), followed by 40 ml 4%
paraformaldehyde in 0.1 M phosphate buffer (PB), pH 7.4. The brains
were rapidly removed and stored in 30% sucrose in 0.01 M PBS (pH 7.4)
overnight at 4 C. Serial 20-m-thick coronal sections were cut on a
freezingmicrotome (LeicaMicrosystems, Vienna, Austria). The sections
were stored in anantifreeze solution (30%ethylene glycol, 25%glycerol,
0.05 M PB) at 20 C until used.
Tissue preparation for electron microscopic
immunocytochemistry
For electron microscopy, three mice were treated with colchicine as
described above. One day later, the animals were overdosed with pen-
tobarbital (50 mg/kg body weight, ip) and perfused transcardially, first
with 10 ml 0.01 M PBS (pH 7.4), followed by 40 ml 4% paraformalde-
hyde/0.2% glutaraldehyde in 0.1 M PB (pH 7.4) and then 10 ml 4%
paraformaldehyde in the same buffer. The brains were rapidly removed
and fixed further in 4% paraformaldehyde overnight at 4 C and then
stored in PBS for 24 h at 4 C. Serial 25-m-thick coronal sections were
cut on a Vibratome through the rostrocaudal extent of the hypothala-
mus, collected in PBS, and stored in antifreeze solution at 20 C until
used.
Light microscopic double-labeling immunocytochemistry
for CB1 and TRH
Every fourth section containing the PVNwas incubated in a mixture
of 0.5% Triton X-100 and 0.5% H2O2 in PBS for 15 min to improve
antibody penetration and remove endogenous peroxidase activity. The
sections were treated with 2% normal horse serum in PBS for 20 min to
reduce nonspecific antibody binding. Then, the sections were immersed
(for 2 d at 4 C) in a 1:25 dilution of a rabbit antiserum directed against
the C-terminal 31 amino acids (443–473) of mouse CB1 (antibody code
no. CB1-2003, bleeding date July 5, 2003) (13) in antibody diluent PBS
containing 2% normal horse serum, 0.2% Kodak Photo-Flo (Eastman
Kodak, Rochester, NY), and 0.2% sodium azide]. Thereafter, the sec-
tionswere rinsed inPBSand incubated inbiotinylateddonkeyanti-rabbit
IgG (1:500; Jackson ImmunoResearch, West Grove, PA) for 2 h, fol-
lowedby incubation in avidin-biotin-peroxidase complex (ABC,1:1000;
Vector, Burlingame, CA). The immunolabeling was visualized with a
peroxidase developer consisting of 0.05% diaminobenzidine (DAB),
0.15% nickel ammonium sulfate, and 0.005% H2O2 in 0.05 M Tris
buffer (pH 7.6).
The resultant reactionproductwas silver intensifiedusing theGallyas
method (14) to allow identification of CB1-immunoreactive (IR) axons
by its black coloration. After additional washes, the sections were incu-
bated in rabbit serum against TRH (no. 31) (15) at 1:8000 dilution for
2 d at 4 C. The sections were then washed in PBS and incubated in
biotinylated donkey anti-rabbit IgG (Jackson ImmunoResearch) at
1:500 dilution for 2 h, and after additional washes in PBS, incubated in
ABC at 1:1000 dilution for 2 h. After three washes in PBS, the reaction
wasdeveloped in0.025%DABcontaining0.0036%H2O2 in0.05MTris
buffer (pH7.6), to yield a contrasting brown, cytoplasmic reaction prod-
uct in neuronal perikarya. The specificity of the rabbit CB1 antiserum
was described elsewhere (10, 13).
Electron microscopic double-labeling
immunocytochemistry for CB1 and TRH
Sections prepared for electron microscopy were treated with 1%
sodium borohydride in 0.1 M PB for 30 min, followed by 0.5%H2O2 in
PBS for 15 min. To improve antibody penetration, the sections were
cryoprotected in 15% sucrose in PBS for 15 min and in 30% sucrose in
PBSovernight (4C)and thenquickly frozenon liquidnitrogen.To reduce
the nonspecific antibody binding, the sections were treated with 2%
normal horse serum in PBS for 20min at room temperature. The sections
were then incubated in 1:900 dilution of a goat antiserum to CB1 [di-
rected against the C-terminal 31 amino acids (443–473) of mouse CB1
(16)] mixed with 1:7500 dilution of the rabbit antiserum to TRH for 4 d
at 4 C and then incubated in biotinylated donkey anti-sheep IgG (1:500;
Jackson ImmunoResearch) for 1 d at 4 C. After rinsing in PBS and 0.1%
coldwater fish gelatin (ElectronMicroscopy Sciences, FortWashington,
PA)/1% BSA in PBS, the sections were incubated in donkey anti-rabbit
IgG conjugated with 0.8-nm colloidal gold (Electron Microscopy Sci-
ences) diluted at 1:100 in PBS containing 0.1% cold water fish gelatin
and1%BSA for 2 h at room temperature. The sectionswere thenwashed
in the same diluent and PBS, followed by a 10-min treatment in 1.25%
glutaraldehyde in PBS. After rinsing in 0.2M sodium citrate (pH7.5), the
gold particles were silver intensified with the IntenseM Kit (Amersham,
Buckinghamshire, UK). Finally, the sectionswere incubated inABCElite
working solution (1:1000; Vector) for 2 h at room temperature. Immu-
noreactivity of CB1 was detected with 0.05% DAB, 0.15% nickel am-
monium sulfate, and 0.005% H2O2 in 0.05 M Tris buffer (pH 7.6).
Sectionswere thenosmicated for30min in1%osmiumtetroxide, treated
with 2% uranyl acetate in 70% ethanol for 30 min, dehydrated in an
ascending series of ethanol followed by propylene oxide, and flat-em-
bedded in Durcupan ACM epoxy resin (Fluka Chemika, Buchs, Swit-
zerland) between glass microscope slides precoated with a liquid release
agent (Electron Microscopy Sciences). The resin was allowed to poly-
merize at 56 C for 2 d. Ultrathin sections (50–60 nm) were cut from a
layer of embedded Vibratome sections 2–4 m below the surface with a
Leica ultracut UCT ultramicrotome (Leica Microsystems), collected in
ribbons onto Formvar-coated single-slot grids, contrasted with 2% lead
citrate, and examined with a Jeol-100C transmission electron micro-
scope. The specificity of the goat rabbit CB1 antiserum was described
elsewhere (16).
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Ultrastructural examination of CB1-IR innervation of
TRH neurons in the PVN
TRH neurons from the medial parvicellular subdivision of the PVN
at themidlevel of the nucleus,where themajority of theTRHneurons are
hypophysiotropic (17), were selected for electron-microscopic examina-
tion from all three animals used for the ultrastructural study. The num-
bers of immunoreactive axon terminals forming either symmetric or
asymmetric synapses on the perikarya or dendrites of TRHneuronswere
determined. The synapses were categorized as symmetric or asymmetric
synapses according to the criteria of Gray (18). These morphological
characteristics were confirmed on neighboring ultrathin sections.
Results
CB1 immunoreactivity appeared as fine, punctuate labeling in
axons and axon terminals densely innervating all parvicellular
subdivisions of the PVN (Fig. 1, A and B) but absent from some
regions of the hypothalamus, like the suprachiasmatic nucleus
(Fig. 1C), establishing specificity of the reaction. In the PVN,
CB1-IR axon terminals marked by the black, silver/gold-inten-
sified reaction productwere closely apposed to the brown,DAB-
immunolabeled cell bodies and proximal dendrites of all TRH
neurons. In most instances, TRH neurons were surrounded by
numerous CB1-IR boutons (Fig. 1B).
Ultrastructural analysis of double-labeled preparations dem-
onstrated that CB1-IR axons frequently established synaptic as-
sociationswith hypophysiotropic TRHneurons (Figs. 2–4). The
most intense CB1 signal was generally observed in the preter-
minal portion of the CB1-IR axons. The terminal portion of
CB1-IR axons contained only a relatively weaker signal primar-
ily in the region farthest from the synapse (Figs. 2–4).Tracing the
juxtaposed CB1-IR terminals and TRH-IR neurons through a
series of ultrathin sections, both symmetric (Fig. 2) and asym-
metric (Figs. 3 and 4) synaptic specializations were observed on
both the perikarya and dendrites of TRH-containing neurons.
Analysis of 21 synapses between TRH neurons and CB1-IR ter-
minals revealed 13 asymmetric and eight symmetric synaptic
associations in the PVN.
Discussion
After discovery of the endogenous cannabinoid system and its
role in the regulation of energy homeostasis, the number of re-
search communications describing the role of cannabinoids in
the regulation of hypothalamic functions exploded. CB1-immu-
noreactivity is discretely localized to several hypothalamic nuclei
but absent from the suprachiasmatic and lateral mammillary
nuclei (10).Despite the increasing number of functional research
data, little is known about the hypothalamic neuronal groups
innervated by CB1-containing axons.
In the present study, we demonstrate that CB1-containing
axon terminals densely innervate the hypophysiotropic TRH
neurons in the PVN. In addition, we show at the ultrastructural
level that theCB1-immunoreactivity is present in both excitatory
and inhibitory terminals forming synapses on TRH neurons.
The observed presynaptic location of CB1 is in agreement
with the retrograde signaling role of endocannabinoids released
from the postsynaptic structures to influence presynaptic func-
tions (5). This concept is supported by the presence of endocan-
nabinoid-synthesizing enzymes associatedwith the surface of the
postsynaptic cells near the synapses (4). Upon activation of the
postsynaptic cells, the synthesized endocannabinoids are re-
leased; they reach the presynaptic terminal by diffusion and bind
to CB1 (4, 5). By inhibiting the N- and P/Q-type voltage-acti-
vated Ca2 channels, the receptor then suppresses the neuro-
transmitter release from the terminal (4). There are at least two
ways bywhich the endocannabinoid retrograde signaling system
can be activated. First, an increased firing of presynaptic axons
results in a Ca2 efflux into the postsynaptic neuron leading to
endocannabinoid release and concomitant activation of CB1 on
the presynaptic terminal resulting in inhibition of transmitter
release (4, 5). This is the mechanism of the depolarization-in-
duced suppression of inhibition (DSI) and excitation (DSE) (4,
5). The DSI and DSE are very well known phenomena in the
hippocampus and play important role in learning (5). DSI has
also been described in the hypothalamus (19). The second mode
of activation of the endocannabinoid signaling is via peripheral
hormones (12, 20). Ghrelin and glucocorticoids increase endo-
cannabinoid synthesis within the hypothalamus, whereas leptin
inhibits it (12, 19, 20). Data from our group have demonstrated
that a direct effect of ghrelin on parvicellular neurons of the PVN
inhibits the glutamatergic input of these cells (20). Because this
effect of ghrelin can be blocked by inhibition of the endocan-
nabinoid synthesis and also by pharmacological antagonism of
CB1 (20), we have proposed that the effect of ghrelin on the
excitatory input of parvicellular neurons is mediated by the en-
FIG. 1. A, Low-power photomicrograph illustrates the distribution of CB1-IR axons (black) and TRH-containing neurons (brown) in the caudal level of the
PVN; B, high-power magnification of CB1-IR axon varicosities contacting perikarya (arrows) and proximal dendrites (arrowheads) of labeled TRH neurons
in the medial parvicellular subdivision of the PVN; C, low-power micrograph illustrates the absence of CB1-IR axons in the suprachiasmatic nucleus.
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docannabinoid retrograde signaling system. Di et al. (12) have
observed that acute effects of glucocorticoids on the excitatory
input of parvicellular neurons in the PVN are also mediated by
endocannabinoid retrograde signaling. In contrast, adirect effect
of leptin inhibits the endocannabinoid synthesis in lateral hy-
pothalamic neurons and, therefore, inhibits the DSI of these
cells (19).
Although exogenous administration of the plant cannabi-
noid 9THC decreases serum TSH and thyroid hormone lev-
els (11), and the endocannabinoids can inhibit the glutama-
tergic input of TRH neurons (12), it is currently unclear how
and under which circumstances endocannabinoids regulate
TRH neurons.
An interesting observation in the study is the electron micro-
scopic demonstration that CB1 axons in contact with hypophy-
siotropic TRH neurons establish both symmetric and asymmet-
ric type synapses. Because symmetric synapses are generally
associatedwith inhibitory and asymmetric synapses with a stim-
ulatory action (21) and the hypophysiotropic neurons are
densely innervated by axons containing either -aminobutyric
acid (GABA), the main inhibitory transmitter, or glutamate, the
main excitatory transmitter, the above observation suggests that
CB1 triggered regulatory mechanisms are capable of interacting
withbothGABAergic andglutamatergic inputs ofTRHneurons.
This is not unusual for CB1, because both GABAergic and glu-
tamatergic axons contain CB1 in the hippocampus (22, 23).
Therefore, 9THC should suppress simultaneously a portion of
both the inhibitory and excitatory input of theTRHneurons that
contain CB1. The inhibitory effect of9THCon theHPT axis is,
therefore, the net effect of this substance on the excitatory and
inhibitory inputs of TRH neurons. This would suggest that the
CB1-containing excitatory input of TRH neurons is more active
under basal conditions than theCB1-containing inhibitory input
of these cells.
In contrast to the exogenous treatment with cannabinoids,
the release of endogenous cannabinoids may separately influ-
ence the two types of inputs on the same cell. Because fasting
increases the hypothalamic level of endocannabinoids (7) and
ghrelin, which has an increased level during fasting (24), inhibits
the glutamatergic input of parvicellular neurons in the PVN via
the endocannabinoid system (20),wehypothesize that inhibition
of glutamatergic input by endocannabinoids may contribute to
the fasting-induced inhibition of hypophysiotropic TRH neu-
rons. Interestingly, however, the orexigenic neuropeptide Y
(NPY)/agouti-related protein and the anorexigenic -melano-
cyte-stimulating hormone/cocaine-and amphetamine-regulated
transcript neurons of the arcuate nucleus thatmediate the effects
of fasting and leptin administration on hypophysiotropic TRH
neurons (1) do not express CB1 (8). Because NPY can inhibit
glutamate release from nerve terminals in the cortex through the
inhibition of N- and P/Q-type Ca2 channels (25), the same
channel that is inhibited by the CB1 (4), the endocannabinoid
FIG. 2. Electron micrographs showing symmetric-type synaptic
specializations between CB1-containing axon terminals and TRH-
containing perikarya in the PVN. The TRH-IR perikarya (TRH) are identified
with highly electron-dense silver-coated gold label, whereas the CB1-IR
terminals are recognized by the presence of the medium electron-dense
Ni-DAB (arrowheads). Arrows point to the synapses between the CB1- and
TRH-IR structures. Scale bars, 500 nm.
FIG. 3. Electron micrographs of an asymmetric-type axosomatic synapse
between a CB1-IR axon terminal labeled with the moderately electron-
dense Ni-DAB precipitate (arrowhead), and a TRH-IR perikaryon (TRH)
labeled with highly electron-dense silver-gold particles. A, High-
magnification image of the asymmetric synapse. Arrows point to the
synaptic specialization. B, Low-magnification image of the innervated TRH
neuron. Arrowhead points to the CB1-IR terminal. Scale bars, 500 nm (A)
and 2 m (B).
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signaling may be involved in the mediation of the effect of NPY
on the glutamate release. Therefore, we hypothesize that the
increased release of NPY in fasted animals may result in endo-
cannabinoid release from the hypophysiotropic TRH neurons,
leading to suppression of glutamatergic input of these neurons
via CB1. This way, NPYmay block the excitatory input of TRH
neurons,which in turnmayoriginate fromleptin-insensitiveneu-
ronal groups located outside the arcuate nucleus. This putative
mechanism may contribute to the fasting-induced inhibition of
the HPT axis.
Because inflammation also increases the hypothalamic level
of anandamide (26), the endocannabinoid system may also be
involved in the inflammation-induced inhibitionof thehypophy-
siotropic TRH neurons.
In summary, we conclude that the hypophysiotropic TRH
neurons are densely innervated byCB1-containing axons. The
presence of CB1 in both inhibitory and excitatory axons in-
nervating the TRH neurons suggests that the TRH neurons
can regulate their own excitatory and inhibitory inputs via the
retrograde endocannabinoid signaling system.
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